Use of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Amateur Sports – Efficacy and Safety: A Review of Current Literature
DOI:
https://doi.org/10.12775/QS.2026.63.73234Keywords
NSAIDs, amateur athletes, weekend warriors, sports medicine, recovery, renal injury, topical NSAIDsAbstract
Objective: To evaluate current evidence on the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in amateur athletes, with particular emphasis on pain relief, recovery, performance outcomes, and adverse health effects.
Methods: This review synthesised recent literature on NSAID use in physically active populations, with a focus on clinical efficacy, usage patterns, and exercise-related adverse effects.
Results: NSAID use in amateur sport is common, frequently self-directed, and often prophylactic. Although these agents may provide modest short-term analgesia, controlled studies do not show consistent benefits for performance, strength recovery, training adaptation, or return to play. Mechanistically, NSAIDs inhibit prostaglandin-mediated pathways involved not only in pain and inflammation, but also in renal perfusion, gastrointestinal mucosal protection, and exercise-related tissue adaptation.
During prolonged or high-intensity exercise, particularly in endurance settings characterised by dehydration and heat stress, NSAID exposure may impair renal autoregulation and increase the risk of acute kidney injury. It may also aggravate gastrointestinal mucosal injury and permeability. Cardiovascular risk remains less clearly defined in athletes, but remains clinically relevant, especially in older individuals or those with pre-existing risk factors.
Conclusions: NSAIDs should not be used routinely to prevent expected soreness or to support endurance participation. Their clearest role is brief, individualised use for selected acute injuries, in which analgesia must not be mistaken for accelerated healing.
For general practitioners, the key recommendation is cautious prescribing at the lowest effective dose for the shortest necessary duration, combined with explicit counselling on renal, gastrointestinal, and cardiovascular risks and consideration of safer alternatives, including topical NSAIDs, paracetamol, load modification, and rehabilitation.
References
1. Wiatrak A, Mosiejczuk H, Szylińska A, Rył A, Turoń-Skrzypińska A, Maziarz A, Rotter I. The effect of smoking and physical activity level on exercise capacity in older adults. Journal of Education, Health and Sport. 2018;8(11):240-252. https://doi.org/10.5281/zenodo.1482851.
2. Lipman GS, Shea K, Christensen M, Phillips C, Burns P, Higbee R, Koskenoja V, Eifling K, Krabak BJ. Ibuprofen versus placebo effect on acute kidney injury in ultramarathons: A randomised controlled trial. Emerg Med J. 2017;34(10):637-642. https://doi.org/10.1136/emermed-2016-206353.
3. Alaranta A, Alaranta H, Heliövaara M, Airaksinen M, Helenius I. Use of prescription drugs in athletes. Sports Med. 2008;38(6):449-463. https://doi.org/10.2165/00007256-200838060-00002.
4. Warden SJ. Prophylactic use of NSAIDs by athletes: A risk/benefit assessment. Phys Sportsmed. 2010;38(1):132-138. https://doi.org/10.3810/psm.2010.04.1770.
5. Kozłowski P, Cuch B, Kozłowska M, Kozłowska K, Jędrzejewska B. Analysis of habits and behaviours related to the use of over-the-counter painkillers. Journal of Education, Health and Sport. 2015;5(3):174-182. https://doi.org/10.5281/zenodo.16307.
6. Nieman DC, Henson DA, Dumke CL, Oley K, McAnulty SR, Davis JM, Murphy EA, Utter AC, Lind RH, McAnulty LS, Morrow JD. Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav Immun. 2006;20(6):578-584. https://doi.org/10.1016/j.bbi.2006.02.001.
7. Mackey AL, Rasmussen LK, Kadi F, Schjerling P, Helmark IC, Ponsot E, Aagaard P, Durigan JLQ, Kjaer M. Activation of satellite cells and the regeneration of human skeletal muscle are expedited by ingestion of nonsteroidal anti-inflammatory medication. FASEB J. 2016;30(6):2266-2281. https://doi.org/10.1096/fj.201500198R.
8. van Wijck K, Lenaerts K, van Loon LJC, Peters WHM, Buurman WA, Dejong CHC. Aggravation of exercise-induced intestinal injury by ibuprofen in athletes. Med Sci Sports Exerc. 2012;44(12):2257-2262. https://doi.org/10.1249/MSS.0b013e318265dd3d.
9. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-779. https://doi.org/10.1016/S0140-6736(13)60900-9.
10. Bally M, Dendukuri N, Rich B, Nadeau L, Brophy JM. Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909. https://doi.org/10.1136/bmj.j1909.
11. Tscholl PM, Vaso M, Weber A, Dvořák J. High prevalence of medication use in professional football tournaments including the World Cups between 2002 and 2014: A narrative review with a focus on NSAIDs. Br J Sports Med. 2015;49(9):580-582. https://doi.org/10.1136/bjsports-2015-094784.
12. Almekinders LC. Anti-inflammatory treatment of muscular injuries in sport: An update of recent studies. Sports Med. 1999;28(6):383-388. https://doi.org/10.2165/00007256-199928060-00001.
13. Lilja M, Mandić M, Apró W, Melin M, Olsson K, Rosenborg S, Gustafsson T, Lundberg TR. High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults. Acta Physiol (Oxf). 2018;222(2):e12948. https://doi.org/10.1111/apha.12948.
14. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Am J Med. 1998;104(3A):2S-8S. https://doi.org/10.1016/S0002-9343(97)00203-9.
15. Peake JM, Neubauer O, Della Gatta PA, Nosaka K. Muscle damage and inflammation during recovery from exercise. J Appl Physiol (1985). 2017;122(3):559-570. https://doi.org/10.1152/japplphysiol.00971.2016.
16. Trappe TA, White F, Lambert CP, Cesar D, Hellerstein M, Evans WJ. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab. 2002;282(3):E551-E556. https://doi.org/10.1152/ajpendo.00352.2001.
17. Trappe TA, Carroll CC, Dickinson JM, LeMoine JK, Haus JM, Sullivan BE, Lee JD, Jemiolo B, Weinheimer EM, Hollon CJ. Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. Am J Physiol Regul Integr Comp Physiol. 2011;300(3):R655-R662. https://doi.org/10.1152/ajpregu.00611.2010.
18. Kaux JF, Forthomme B, Le Goff C, Crielaard JM, Croisier JL. Current opinions on tendinopathy. J Sports Sci Med. 2011;10(2):238-253. https://pmc.ncbi.nlm.nih.gov/articles/PMC3761855/ (Access: 20.04.2026).
19. Gorski T, Cadore EL, Pinto SS, da Silva EM, Correa CS, Beltrami FG, Kruel LFM. Use of NSAIDs in triathletes: Prevalence, level of awareness and reasons for use. Br J Sports Med. 2011;45(2):85-90. https://doi.org/10.1136/bjsm.2009.062166.
20. Rudgard WE, Hirsch CA, Cox AR. Amateur endurance athletes’ use of non-steroidal anti-inflammatory drugs: A cross-sectional survey. Int J Pharm Pract. 2019;27(1):105-107. https://doi.org/10.1111/ijpp.12469.
21. Küster M, Renner B, Oppel P, Niederweis U, Brune K. Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: A cohort study. BMJ Open. 2013;3(4):e002090. https://doi.org/10.1136/bmjopen-2012-002090.
22. Rosenbloom CJ, Morley FL, Ahmed I, Cox AR. Oral non-steroidal anti-inflammatory drug use in recreational runners participating in Parkrun UK: Prevalence of use and awareness of risk. Int J Pharm Pract. 2020;28(6):561-568. https://doi.org/10.1111/ijpp.12646.
23. Harle CA, Danielson EC, Derman W, Stuart M, Dvořák J, Smith L, Hainline B. Analgesic management of pain in elite athletes: A systematic review. Clin J Sport Med. 2018;28(5):417-426. https://doi.org/10.1097/JSM.0000000000000604.
24. Dubois B, Esculier JF. Soft-tissue injuries simply need PEACE and LOVE. Br J Sports Med. 2020;54(2):72-73. https://doi.org/10.1136/bjsports-2019-101253.
25. Pham H, Spaniol F. The efficacy of non-steroidal anti-inflammatory drugs in athletes for injury management, training response, and athletic performance: A systematic review. Sports (Basel). 2024;12(11):302. https://doi.org/10.3390/sports12110302.
26. Mojsiewicz K, Kempińska-Podhorodecka A. The most common injuries, rehabilitation and recovery among soccer practitioners. Journal of Education, Health and Sport. 2021;11(5):65-77. https://doi.org/10.12775/JEHS.2021.11.05.007.
27. Cornu C, Grange C, Regalin A, Munier J, Ounissi S, Reynaud N, Kassai-Koupai B, Sallet P, Nony P. Effect of non-steroidal anti-inflammatory drugs on sport performance indices in healthy people: A meta-analysis of randomized controlled trials. Sports Med Open. 2020;6(1):20. https://doi.org/10.1186/s40798-020-00247-w.
28. Duchman KR, Lemmex DB, Patel SH, Ledbetter L, Garrigues GE, Riboh JC. The effect of non-steroidal anti-inflammatory drugs on tendon-to-bone healing: A systematic review with subgroup meta-analysis. Iowa Orthop J. 2019;39(1):107-119. https://doi.org/10.17061/ijor.v39i1.836.
29. Hughes JM, McKinnon CJ, Taylor KM, Kardouni JR, Bulathsinhala L, Guerriere KI, Popp KL, Bouxsein ML, Proctor SP, Matheny RW. Nonsteroidal anti-inflammatory drug prescriptions are associated with increased stress fracture diagnosis in the U.S. Army population. J Bone Miner Res. 2019;34(3):429-436. https://doi.org/10.1002/jbmr.3616.
30. Al Farii H, Farahdel L, Frazer A, Salimi A, Bernstein M. The effect of NSAIDs on postfracture bone healing: A meta-analysis of randomized controlled trials. OTA Int. 2021;4(2):e092. https://doi.org/10.1097/OI9.0000000000000092.
31. Fitzpatrick D, Leckie T, Heine G, Hodgson L. The use of pain killers (NSAIDs) in athletes: How large is the risk. J Sci Med Sport. 2025;28(3):198-205. https://doi.org/10.1016/j.jsams.2024.11.010.
32. Pannone E, Abbott R. What is known about the health effects of non-steroidal anti-inflammatory drug (NSAID) use in marathon and ultraendurance running: A scoping review. BMJ Open Sport Exerc Med. 2024;10(1):e001846. https://doi.org/10.1136/bmjsem-2023-001846.
33. Hodgson LE, Walter E, Venn RM, Galloway R, Pitsiladis Y, Sardat F, Forni LG. Acute kidney injury associated with endurance events—is it a cause for concern? A systematic review. BMJ Open Sport Exerc Med. 2017;3(1):e000093. https://doi.org/10.1136/bmjsem-2015-000093.
34. Tidmas V, Brazier J, Bottoms L, Muniz D, Desai T, Hawkins J, Sridharan S, Farrington K. Ultra-endurance participation and acute kidney injury: A narrative review. Int J Environ Res Public Health. 2022;19(24):16887. https://doi.org/10.3390/ijerph192416887.
35. Vauthier JC, Touzé C, Mauvieux B, Hingrand C, Poussel M, Chenuel B. Increased risk of acute kidney injury in the first part of an ultra-trail: Implications for abandonment. Physiol Rep. 2024;12(9):e15935. https://doi.org/10.14814/phy2.15935.
36. Linder BA, Jeong S, Stute NL, El-Kurd OB, Vondrasek JD, Pasternak A, Bagley JR, Watso JC, Schlader ZJ, Babcock MC, Grosicki GJ, Robinson AT. Hypohydration augments the acute increase in urinary biomarkers of kidney injury following the 100-mile Western States Endurance Run. J Appl Physiol (1985). 2025;139(5):1379-1391. https://doi.org/10.1152/japplphysiol.00289.2025.
37. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P. Cardiovascular safety of non-steroidal anti-inflammatory drugs: Network meta-analysis. BMJ. 2011;342:c7086. https://doi.org/10.1136/bmj.c7086.
38. Dalle S, Poffe C, Hiroux C, Ramaekers M, Deldicque L, Koppo K. Ibuprofen does not impair skeletal muscle regeneration upon cardiotoxin-induced injury. Physiol Res. 2020;69(5):847-859. https://doi.org/10.33549/physiolres.934482.
39. Pountos I, Panteli M, Walters G, Giannoudis PV. NSAIDs inhibit bone healing through the downregulation of TGF-β3 expression during endochondral ossification. Injury. 2021;52(6):1420-1426. https://doi.org/10.1016/j.injury.2021.01.007.
40. Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;2015(6):CD007402. https://doi.org/10.1002/14651858.CD007402.pub3.
41. Predel HG, Giannetti B, Seigfried B, Novellini R, Menke G. A randomised, double-blind, placebo-controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain. J Int Med Res. 2013;41(4):1187-1202. https://doi.org/10.1177/0300060513487639.
42. Hainline B, Derman W, Vernec A, Budgett R, Deie M, Dvořák J, Harle C, Herring SA, McNamee M, Meeuwisse W, Moseley GL, Omololu B, Orchard J, Pipe A, Pluim BM, Ræder J, Siebert C, Stewart M, Stuart M, Turner JA, Ware M, Zideman D, Engebretsen L. International Olympic Committee consensus statement on pain management in elite athletes. Br J Sports Med. 2017;51(17):1245-1258. https://doi.org/10.1136/bjsports-2017-097884.
43. Yargiç MP, Torgutalp ŞŞ, Erdağı K. Nonsteroidal anti-inflammatory drugs and paracetamol use in elite-level Olympic-style weightlifters: A survey study. J Sports Med Phys Fitness. 2021;61(7):991-996. https://doi.org/10.23736/S0022-4707.21.11604-4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dawid Ocicki, Igor Nowiński, Pola Kobryń, Michał Bojarski, Michał Kwiatkowski, Michał Fryderyk Musielak, Iga Kobryń, Aleksandra Zybert, Aleksandra Borowska, Jakub Grabowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 43
Number of citations: 0
